CXSB0900032 | 重组人CD22单克隆抗体注射液 | Recombinant anti-CD22 humanized monoclonal antibody | Injection | Biological Products | Supplementary Application | 2010-01-08 | 深圳龙瑞药业有限公司 | Lonn Ryonn PHARMA Ltd | Certificate Issued | 2010-11-23 | view |
CXSL0600064 | 重组人CD22单克隆抗体注射液 | Recombinant anti-CD22 humanized monoclonal antibody | Injection | Biological Products(2) | New Drug Application | 2007-01-22 | 深圳龙瑞药业有限公司 | Lonn Ryonn PHARMA Ltd | Certificate Issued | 2008-03-24 | view |
CXSL0600048 | 重组人CD22单克隆抗体注射液 | Recombinant anti-CD22 humanized monoclonal antibody | Injection | Biological Products(2) | New Drug Application | 2006-10-23 | 深圳龙瑞药业有限公司 | Lonn Ryonn PHARMA Ltd | Certificate Issued | 2008-12-22 | view |
CXSL0500026 | 重组人CD22单克隆抗体注射液 | Recombinant anti-CD22 humanized monoclonal antibody | Injection | Biological Products(2) | New Drug Application | 2005-04-01 | 深圳龙瑞药业有限公司 | Lonn Ryonn PHARMA Ltd | Certificate Issued | 2006-08-24 | view |
CXSL0500025 | 重组人CD22单克隆抗体注射液 | Recombinant anti-CD22 humanized monoclonal antibody | Injection | Biological Products(2) | New Drug Application | 2005-04-01 | 深圳龙瑞药业有限公司 | Lonn Ryonn PHARMA Ltd | Certificate Issued | 2006-08-24 | view |